Volume 5, Number 3—June 1999
Application of Data Mining to Intensive Care Unit Microbiologic Data1
|Left Denominator||Right Numerator||1||2||3||4||5||6||7||Interpretation|
|Staphylococcus aureus Source TRACHASPc||==>||R~Oxacillina, b R~Clindamycin R~Erythromycin||0/10||0/8||7/14||Increase in the incidence of oxacillin (ORSA), clindamycin and erythromycin resistance in all S. aureus isolated from tracheal aspirates.|
|NSNosod||==>||R~Ceftazidime||3/88||11/70||Increase in incidence of ceftazidime resistance in all nosocomial isolates.|
|NP_GNRe||==>||R~Piperacilli||0/17||6/14||Increase in the LocSICU incidence of piperacillin resistance in non-pseudo-monas gram-negative bacilli isolated from NSNoso.|
|NP_GNR||==>||R~Piperacillin||1/12||0/14||4/11||4/8||Increase in the LocSICUf incidence of piperacillin resistance in non-pseudo-monas, nosocomial gram- negative bacilli from the SICU.|
|NSNoso LocNICUg||==>||S. aureus||3/26||3/26||2/28||6/27||5/20||3/11||Increase in the incidence of nosocomial S. aureus in nosocomial isolates from the NICU.|
bOxacillin, resistance implies resistance to amoxycillin/clavulanic acid, cephalothin, and cefazolin.
cSourceTRACHASP, tracheal aspirates.
dNSNoso, nosocomial (3 days from admission).
eNP_GNR, non-pseudomonas gram-negative rod.
fLocSICU, location, surgical intensive care unit (SICU).
gLocNICU, location, neonatal intensive care unit (NICU).
- Page created: December 13, 2010
- Page last updated: December 13, 2010
- Page last reviewed: December 13, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)